2005
I.v. infusion of brain-derived neurotrophic factor gene-modified human mesenchymal stem cells protects against injury in a cerebral ischemia model in adult rat
Nomura T, Honmou O, Harada K, Houkin K, Hamada H, Kocsis J. I.v. infusion of brain-derived neurotrophic factor gene-modified human mesenchymal stem cells protects against injury in a cerebral ischemia model in adult rat. Neuroscience 2005, 136: 161-169. PMID: 16229956, PMCID: PMC2605391, DOI: 10.1016/j.neuroscience.2005.06.062.Peer-Reviewed Original ResearchConceptsBrain-derived neurotrophic factorMesenchymal stem cell groupBrain-derived neurotrophic factor contributesMiddle cerebral artery occlusionStem cell groupCerebral artery occlusionCerebral ischemia modelMesenchymal stem cellsNeurotrophic factorArtery occlusionCell groupsIschemia modelPermanent middle cerebral artery occlusionRat cerebral ischemia modelHuman mesenchymal stem cellsBrain-derived neurotrophic factor (BDNF) geneStem cellsControl sham groupTreadmill stress testRats 6 hFactor contributesNeurotrophic factor geneIntraluminal vascular occlusionAdult bone marrowCerebral ischemia
1998
A summary of mechanistic hypotheses of gabapentin pharmacology
Taylor C, Gee N, Su T, Kocsis J, Welty D, Brown J, Dooley D, Boden P, Singh L. A summary of mechanistic hypotheses of gabapentin pharmacology. Epilepsy Research 1998, 29: 233-249. PMID: 9551785, DOI: 10.1016/s0920-1211(97)00084-3.Peer-Reviewed Original ResearchConceptsAmyotrophic lateral sclerosisNon-vesicular GABA releaseCellular mechanismsVoltage-sensitive Ca2Specific amino acid transportersGabapentin bindsGABA releaseNeuronal deathElectrophysiology resultsAnticonvulsant drugsLateral sclerosisNeuroprotective activityNeurobehavioral actionsPharmacological actionsGabapentinAnimal modelsHuman whole bloodBrain tissueMonoamine neurotransmittersAmino acid transportersWhole bloodAcid transportersAuxiliary subunitsPharmacologyRate of synthesis